New drug for Alzheimer’s disease approved for use in Japan
On the 21st at the Ministry of Health, Labor and Welfare, experts discussed the new drug ”Lecanemab” for Alzheimer’s disease
The drug, made by a Japanese and American company together, is said to be able to slow the progression of Alzheimer’s disease.
Experts confirm that the drug works and say there are no major safety concerns
and approved to use it in Japan
この薬を使うことができる人については、アルツハイマー病になったばかりの人などにすると決めました
It was decided that only people who had just had Alzheimer’s disease could use this drug .
日本での薬の値段は、まだ決まっていません
The price of the drug in Japan has not yet been decided.
In America, it costs an average of 3.85 million yen per person per year.
This drug is likely to be ready for use by December this year at the earliest.
Todaii Japanese is a website for learning and reading Japanese news integrating various features such as dictionary, practice, testing, ...
https://todaiinews.com
todai.easylife@gmail.com
(+84) 865 924 966
315 Truong Chinh, Khuong Mai, Thanh Xuan, Hanoi
Home
Video
JLPT Test
Dictionary
Lesson
Topic
